Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review of chalcone derivatives as antileishmanial agents
Marcos V. Palmeira-Mello, Bárbara Abrahim-Vieira, Thaisa Francielle Souza Domingos, et al.
European Journal of Medicinal Chemistry (2018) Vol. 150, pp. 920-929
Closed Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids
Bo Zhang
European Journal of Medicinal Chemistry (2019) Vol. 168, pp. 357-372
Closed Access | Times Cited: 278
Chalcone Derivatives: Role in Anticancer Therapy
Yang Ouyang, Juanjuan Li, Xinyue Chen, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 894-894
Open Access | Times Cited: 239
Anticancer Activity of Natural and Synthetic Chalcones
Teodora Constantinescu, Claudiu N. Lungu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11306-11306
Open Access | Times Cited: 114
Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives
Jagjit Singh Dhaliwal, Said Moshawih, Khang Wen Goh, et al.
Molecules (2022) Vol. 27, Iss. 20, pp. 7062-7062
Open Access | Times Cited: 70
In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2
Balaji Gowrivel Vijayakumar, Deepthi Ramesh, Annu Joji, et al.
European Journal of Pharmacology (2020) Vol. 886, pp. 173448-173448
Open Access | Times Cited: 133
Current scenario of ferrocene-containing hybrids for antimalarial activity
Jiaqi Xiao, Zhou Sun, Fangong Kong, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111791-111791
Closed Access | Times Cited: 77
Identification of Unique Quinazolone Thiazoles as Novel Structural Scaffolds for Potential Gram-Negative Bacterial Conquerors
Jie Wang, Mohammad Fawad Ansari, Cheng‐He Zhou
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 11, pp. 7630-7645
Closed Access | Times Cited: 75
Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug‐resistant Plasmodium falciparum
Lian‐Shun Feng, Zhi Xu, Le Chang, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 3, pp. 931-971
Closed Access | Times Cited: 66
Chalcone hybrids and their antimalarial activity
Peng Cheng, Linlin Yang, Xiaodan Huang, et al.
Archiv der Pharmazie (2020) Vol. 353, Iss. 4
Closed Access | Times Cited: 58
Linear optical and third-order nonlinear optical properties of anthracene chalcone derivatives doped PMMA thin films
Shivaraj R. Maidur, P. S. Patil
Optik (2019) Vol. 190, pp. 54-67
Closed Access | Times Cited: 55
Molecular Mechanisms of Antiproliferative Effects of Natural Chalcones
Radka Michalková, Ladislav Mirossay, Maria Gazdova, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2730-2730
Open Access | Times Cited: 45
Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 16
Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin/EGFR kinase inhibition
Mohammed M. Amin, Gamal El‐Din A. Abuo‐Rahma, Montaser Sh. A. Shaykoon, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106444-106444
Closed Access | Times Cited: 15
The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115609-115609
Closed Access | Times Cited: 15
Thiourea as a Promising Scaffold for Development of Agents Toward TriTryp Diseases
Alessandra Mendonça Teles de Souza, Bárbara Abrahim-Vieira, Paloma Wetler Meireles Carreiros Assumpção, et al.
ChemistrySelect (2025) Vol. 10, Iss. 1
Closed Access
Development of a novel nitric oxide (NO) production inhibitor with potential therapeutic effect on chronic inflammation
Youzhe Yang, Zhe Wei, A. Teíchmann, et al.
European Journal of Medicinal Chemistry (2020) Vol. 193, pp. 112216-112216
Closed Access | Times Cited: 44
Identification of Chalcone Derivatives as Inhibitors of Leishmania infantum Arginase and Promising Antileishmanial Agents
Andreza R. Garcia, Danielle Maria Perpétua de Oliveira, Jéssica B. de Jesus, et al.
Frontiers in Chemistry (2021) Vol. 8
Open Access | Times Cited: 39
A review on new natural and synthetic anti-leishmanial chemotherapeutic agents and current perspective of treatment approaches.
Nilanjana Majumder, Antara Banerjee, Samiran Saha
Acta Tropica (2023) Vol. 240, pp. 106846-106846
Closed Access | Times Cited: 12
Dinuclear copper(II) complexes with a bridging bis(chalcone) ligand reveal considerable in vitro cytotoxicity on human cancer cells and enhanced selectivity
Zdeněk Trávnı́ček, Ján Vančo, Jan Belza, et al.
Journal of Inorganic Biochemistry (2024) Vol. 252, pp. 112481-112481
Closed Access | Times Cited: 4
Novel cyanochalcones as potential anticancer agents: apoptosis, cell cycle arrest, DNA binding, and molecular docking studies
Mohamed A. Ragheb, Hanan E. Abdelrashid, Emad M. Elzayat, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-19
Closed Access | Times Cited: 4
New chalcone derivatives as effective against SARS‐CoV‐2 agent
Nizami Duran, M. Fatih Polat, Derya Aktaş, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 12
Open Access | Times Cited: 31
Exploring the 2′-Hydroxy-Chalcone Framework for the Development of Dual Antioxidant and Soybean Lipoxygenase Inhibitory Agents
Ioanna Kostopoulou, Andromachi Tzani, Nestor-Ioannis Polyzos, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2777-2777
Open Access | Times Cited: 30
Total Synthesis of the Natural Chalcone Lophirone E, Synthetic Studies toward Benzofuran and Indole-Based Analogues, and Investigation of Anti-Leishmanial Activity
Luca Pozzetti, Roberta Ibba, Sara Rossi, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 463-463
Open Access | Times Cited: 19
A Comprehensive Review of The Molecular Dynamic Study Of Chalcones, Coumarins and Chromones as Selective MAO‐B Inhibitors [2015‐Till Date]
Riya Rachel Thomas, Namitha Chandran, Della Grace Thomas Parambi, et al.
ChemistrySelect (2024) Vol. 9, Iss. 27
Closed Access | Times Cited: 3
Chalcones identify cTXNPx as a potential antileishmanial drug target
Douglas O. Escrivani, Rebecca L. Charlton, Marjolly B. Caruso, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 11, pp. e0009951-e0009951
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top